CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-01 | Doshi Dipal President and CEO | Grant or award | +15,125 | 221,835 | ||
| 2022-08-31 | Doshi Dipal President and CEO | Sale | −171 | $12.00 | $2K | 206,710 |
| 2022-08-30 | Doshi Dipal President and CEO | Sale | −190 | $12.00 | $2K | 206,881 |
| 2022-08-29 | Doshi Dipal President and CEO | Sale | −1,109 | $12.56 | $14K | 207,601 |
| 2022-08-29 | Doshi Dipal President and CEO | Sale | −505 | $13.51 | $7K | 207,096 |
| 2022-08-29 | Doshi Dipal President and CEO | Sale | −25 | $14.00 | $350 | 207,071 |
| 2022-08-25 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −1,551 | $14.18 | $22K | 10,986 |
| 2022-08-24 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +1,117 | $2.10 | $2K | 15,655 |
| 2022-08-24 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −2,817 | $13.52 | $38K | 12,838 |
| 2022-08-24 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −301 | $14.23 | $4K | 12,537 |
| 2022-08-24 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −1,117 | 108,807 | ||
| 2022-08-23 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +1,403 | $2.10 | $3K | 17,447 |
| 2022-08-23 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −2,909 | $13.09 | $38K | 14,538 |
| 2022-08-23 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −1,403 | 109,924 | ||
| 2022-08-22 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +117 | $2.10 | $246 | 16,261 |
| 2022-08-22 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −217 | $13.00 | $3K | 16,044 |
| 2022-08-22 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −117 | 111,327 | ||
| 2022-08-19 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +4,452 | $2.10 | $9K | 24,673 |
| 2022-08-19 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −8,529 | $13.08 | $112K | 16,144 |
| 2022-08-19 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −4,452 | 111,444 |
Page 23 of 26 · 517 trades